Introduction
Several epidemiologic studies have consistently shown that high intake of fruits and vegetables presents a protective action against different cancer types (1). Isoprenoids, widely distributed in fruits and vegetables, are a class of substances with over 22,000 constituents that originate from the mevalonate pathway. In vivo and in vitro protecting actions against some types of cancer were described for β-ionone (BI) (2) (Figure 1a) , a cyclic isoprenoid. Although cell culture studies utilizing diverse cancer cell lines have demonstrated the pronounced effects of geranylgeraniol (GGO) (Figure 1b) , an acyclic isoprenoid, on the induction of apoptosis (3-5) the results of its evaluation in vivo were inconclusive (6).
A proposed mechanism for the inhibition of neoplasia development by isoprenoids such as GGO and BI is based on their ability to posttranscriptionally inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity, thus reducing synthesis of cholesterol and intermediaries of the mevalonate pathway such as farnesyl and geranylgeranyl pyrophosphates (2). These mevalonate derivatives are important for protein farnesylation and geranylgeranylation processes of certain proto-oncogenes (2). Differently from normal cells, preneoplastic and neoplastic liver lesions present a loss in the transcriptional downregulation mechanism of HMG-CoA reductase and of cholesterologenesis by sterols (7). However, in these lesions this enzyme retains sensitivity to isoprenoid-mediated inhibition (2). Thus, isoprenoids could represent potential chemopreventive agents against hepatocarcinogenesis.
The objective of this study was to evaluate the chemopreventive effect of GGO and BI during initiation and promotion phases of chemical hepatocarcinogenesis in rats submitted to the "resistant hepatocyte" (RH) model. Parameters evaluated included preneoplastic lesion (PNL) development, hepatic cell proliferation, apoptosis, DNA damage, activation of nuclear factor kappa B (NF-κB) (8) and plasma cholesterol concentration, an indirect measure of HMG-CoA reductase activity.
Materials and methods
Chemicals GGO was kindly provided by Eisai Co. (Tokyo, Japan). BI, diethylnitrosamine (DEN), 2-acetylaminofluorene (2-AAF), 5-bromo-2'-deoxyuridine (BrdU), dimethylsulfoxide (DMSO), 3,3'-diaminobenzidine and low melting point agarose were purchased from Sigma (St. Louis, USA). The commercial diet was purchased from Purina (Campinas, Brazil). Corn oil (CO) was Mazola (São Paulo, Brazil). Polyclonal anti-placental glutathione S-transferase (GST-P) rabbit antibody was purchased from Medical and Biological Laboratories Co. (Tokyo, Japan). Polyclonal anti-BrdU rat antibody, secondary biotinylated antibody and streptavidin-biotinperoxidase complex (StrepABComplex/HRP Duet, Mouse/Rabbit) were purchased from Dako (Glostrup, Denmark). The total plasma cholesterol kit was purchased from BioSystems (Barcelona, Spain). N-PER and BCA protein assay kit were purchased from Pierce (Rockford, USA). Polyclonal anti-p65 antibody and secondary antibody conjugated to horse radish peroxidase were purchased from Santa Cruz Biotechnology (Santa Cruz, USA). Nitrocellulose membrane (Hybond-C extra) and ECL chemoluminescence kit were purchased from Amersham Biosciences (Piscataway, USA). Other chemicals were of the highest available quality.
Animals and Experimental Protocol
Male Wistar rats from the colony of the Faculty of Pharmaceutical Sciences, initially weighing 40-45 g, maintained in cages of 4 animals, at a constant temperature (22ºC), with 12-h light-dark cycle and receiving water and commercial diet ad libitum, were used. Figure 2 illustrates the experimental protocol design. At the end of a seven-day acclimatization period, with the exception of 12 Wistar rats not submitted to any experimental procedure (normal [N] group), 60 animals were randomly divided into 5 experimental groups. Those of groups GGO8 and GGO16 were treated with GGO (8 and 16 mg/100 g body weight [b.w.], respectively), and those of BI8 and BI16 were treated with BI (8 and 16 mg/100 g b.w., respectively). As both isoprenoids were dissolved in CO (0.25 mL/100 g b.w.), animals receiving only CO (0.25 mL/100 g b.w.) were used as controls (CO group). All treatments were conducted by gavage, daily for 7 consecutive weeks. Rats were submitted to the RH model of hepatocarcinogenesis as follows (9): two weeks after the beginning of the different treatments the animals received an intraperitoneal dose of DEN (20 mg/100 g b.w.) for initiation. Two weeks later the animals received 6 intragastric doses of 2-AAF (3 mg/100 g b.w.), the first four on 4 consecutive days before partial (2/3) hepatectomy and the remaining two (2,5 mg/100 g b.w.) on day 2 and 4 thereafter. All animals were euthanized by light ether anesthesia and exsanguination 5 weeks after DEN administration. One h before sacrifice the rats received a single i.p. injection of BrdU (10 mg/100 g b.w.) dissolved in DMSO and saline (1:3 v/v). The study was conducted in accordance with NIH guidelines for the care and use of laboratory animals.
Visible Hepatocyte Nodules Counting
After the sacrifice the liver was removed from each animal, weighed and examined grossly on the surface and in 3-mm cross-sections for the presence of visible hepatocyte nodules of varied sizes and a generally whitish or yellowish color, different from the hepatic parenchyma. These visible hepatocyte nodules were classified into 3 categories according to their diameter: <1 mm, ≥1 and ≤3 mm, and >3 mm.
Histopathologic Examination
Representative fragments of each liver lobe were fixed in Carnoy's solution (60% methanol, 30% chloroform and 10% glacial acetic acid) for approximately 24 h and included in paraffin. Five µm sections were hematoxylin-eosin (H&E) stained for histopathologic examination that was conducted by an experienced pathologist. Hepatic PNL were classified as mixed (acidophilic and vacuolated or basophilic and vacuolated) foci or nodules according to the criteria established in the literature (10). Hepatocyte foci were considered PNL smaller than one hepatic lobule, whereas hepatocyte nodules comprised spherical PNL larger than one or more hepatic lobules (11).
Immunohistochemistry for GST-P and BrdU.
Histological sections of the liver samples were also processed to be submitted to immunohistochemical reactions in order to detect PNL (foci/nodules) positive for GST-P or hepatocytes positive for BrdU, according to the method described by Hsu et al. (12) . After removal of paraffin the endogenous peroxidase was blocked by 3% hydrogen peroxide in phosphate buffered saline (PBS) for 5 min. Thereafter the sections were incubated overnight at 4°C with primary anti-GST-P rabbit antibody at a 1:1,000 dilution or primary anti-BrdU rat antibody at a 1:60 dilution, in 1% bovine serum albumin. Finally, the sections were incubated for 1 h with secondary biotinylated antibody, thereafter applying the streptavidin-biotin-peroxidase complex. Peroxidase binding sites were detected by incubation with 3,3'-diaminobenzidine (0.5%) and hydrogen peroxide (0.1%) dissolved in PBS, for approximately 2 min at room temperature. Sections were counterstained with hematoxylin.
Hepatocyte foci and nodules staining uniformly and non-uniformly for GST-P were classified as the persistent and remodeling type, respectively (13) (Figure 3a and b). They were measured by the KS-300 program (Kontron Elektronic, Munich, Germany) using a Nikon (Microphot-FXA, Tokyo, Japan) photomicroscope connected with a microcomputer. Data were expressed as GST-P positive PNL number (n/cm 2 ) and area (mm 2 ), and % liver section occupied by these PNL.
In order to evaluate the BrdU labeling index (LI) 1,000 hepatocytes were analyzed per animal, of which 500 in PNL (foci/nodules) areas and 500 in the surrounding normal tissue (14) , using a light microscope (Carl Zeiss, Göttingen, Germany). BrdU LI was expressed as the number of BrdU-positive hepatocyte nuclei x 100/total number of analyzed hepatocytes.
Apoptosis Evaluation
Apoptosis was evaluated in H&E stained liver sections by identification of hepatocytes and corpuscles undergoing apoptosis, according to the criteria established by Goldsworthy et al. (15) . Compact cells with condensed chromatin at the nuclear periphery and with intense acidophilic cytoplasm were considered to be hepatocytes undergoing apoptosis. Corpuscles undergoing apoptosis, in turn, were characterized by acidophilic bodies, fragmentation or lack of chromatin accompanied by cytoplasmatic condensation and/or fragmentation. In order to evaluate the apoptosis index (AI) 1,000 hepatocytes were analyzed per animal, of which 500 in PNL (foci/nodules) areas and 500 in the surrounding normal tissue (14) , using a light microscope (Carl Zeiss, Göttingen, Germany). AI was expressed as the number of hepatocytes and corpuscles undergoing apoptosis x 100/total number of analyzed hepatocytes.
Total Plasma Cholesterol Concentration
Blood was collected by puncture of the abdominal aorta at the time of sacrifice. Immediately after collection it was placed in centrifuge tubes containing 5 mg EDTA and centrifuged at 3,500 g, 4°C for 10 min. Total plasma cholesterol concentration was determined using an enzymatic-spectrophotometric technique. Analysis was performed at 500 nm with a Model U 110 (Hitachi, Tokyo, Japan) spectrophotometer.
p65 Western Blot Analysis
Nuclear protein extracts were prepared from liver samples of the experimental rats, previously stored at -78 o C, using the N-PER TM reagent. Protein concentration was determined with the BCA protein assay kit. Samples of nuclear protein extracts (50 µg) were separated by electrophoresis in 10% denaturing polyacrylamide gel (SDS-PAGE), in 1X Tris-glycine buffer, according to the method by Laemmli (16) . The proteins were then transferred from the gel to a nitrocellulose membrane. Nitrocellulose membrane blockade was performed with PBS containing 5% powdered milk during 1 night at 4 o C. After washing with PBS buffer containing 0.1% Tween 20, it was incubated for 2 h at room temperature with the primary anti-p65 antibody (1:1,000) in PBS buffer containing 0.5% powdered milk, followed by incubation with the secondary antibody conjugated to horse radish peroxidase. The membrane was developed using the ECL chemoluminescence kit. The membrane was then exposed to an X-ray film resulting in approximately 65 kDa bands, corresponding to the expected molecular weight of p65. In order to quantify band intensities the BIO-RAD densitometer (Imaging Densitometer, Model GS-700) with a specific software (Molecular Analyst) was used. Control of the relative amount of the protein of interest was made by previous staining of the nitrocellulose membrane with Coomassie blue (17) .
Hepatic DNA Strand Breakage (Single Cell Electrophoresis -Comet Assay)
DNA strand breakage in samples of the right liver lobe of animals, previously stored at -78 o C, was assessed using the comet assay (18) . Basically the tissues were gently homogenized in PBS at 4 o C and filtered. The isolated cells were then added to a 0.8% low melting point agarose solution in PBS buffer, homogenized and immobilized on a microscope slide which had previously received a layer of 0.5% low melting point agarose. Thereafter these slides were transferred to the lysis solution (2.5 M NaCl, 100 mM EDTA, 10 mM Trizma Base, 10% DMSO, 1% N-laurylsarcosine, pH adjusted to 10 and addition of 1% Triton X-100). After 1 h the slides were washed 3 times for 20 min with water. The slides were placed in a horizontal electrophoresis unit containing the running buffer (300 mM NaOH, 1 mM EDTA, pH >13) where they remained immersed for 20 min at 5 o C. Electrophoresis was performed during 20 min at 0,9 V/cm at 5 o C. The resulting comets were neutralized with 0.4 M Tris 3 times for 5 min, fixed and stained according to the method described by Nadin et al. (19) where silver is used instead of ethidium bromide. Cells extracted from livers of rats not submitted to the RH model (N group), treated or not with hydrogen peroxide (10% final concentration, 15 min at room temperature and under sonication), were used as positive and negative controls, respectively (20) . Length of the comets was evaluated using the previously described image analysis system. One hundred nucleoids per animal were randomly analyzed (50 images per slide). Coded slides were scored blindly. The viability of the liver cells was indirectly determined by analyzing the comet images after electrophoresis (21, 22) . The comet image was considered to be from a non-viable cell when it presented a "cloudy" appearance or a very small head and a tail like a balloon (necrotic or apoptotic cells). The viability of the cell suspension was considered acceptable when the frequency of such images was less than 2% (21, 22) .
Statistical analysis
Sigma Stat 2.0 (Jandel, San Rafael, USA) program was used for the statistical analysis. Fisher's exact test was used when indicated. One-way ANOVA and Student's t tests were used when the results presented a normal distribution and, in the case this did not occur, KruskallWallis and Mann-Whitney's tests were used. To all cases a level of significance of P < 0.05 was applied. Table 1 . No statistically significant differences (P > 0.05) were observed between the different experimental groups regarding the final body weights and relative liver weights. GGO8, GGO16 and BI16 groups, but not GGO8 group, presented higher (P < 0.05) body weight gains compared to CO group (controls). All isoprenoid-treated groups presented higher (P < 0.05) absolute liver weights compared to CO group (controls). These results indicate that GGO and BI did not present toxicity at the used doses. Table 2 presents the data on incidence, mean number per rat and size distribution of visible hepatocyte nodules. When compared to the controls (CO group), animals of GGO16, BI8 and BI16 groups presented a lower incidence (P < 0.05) and mean number (P < 0.05) of hepatocyte nodules. Similar results were observed in animals of GGO8 group, although in this case the difference did not reach statistical significance (P > 0.05). Only animals of GGO16 and BI16 groups presented smaller (P < 0.05) lesions compared to CO group. These inhibitory actions of GGO and BI on visible hepatocyte nodules tended to be more pronounced at the higher dose (16 mg/100 g b.w.) suggesting a dose-response relationship.
Results

Body and liver weights
Incidence, mean number and size distribution of visible hepatocyte nodules
Morphometric quantification of GST-P positive PNL
GST-P is a marker of foci and nodules that can demonstrate more numbers and larger sizes of these putative PNL than other markers in various rat liver carcinogenesis studies (23) . A typical and critical property of hepatocyte foci and nodules is their capability of expressing one of two options: spontaneously remodeling to a normal appearing liver by the majority (95-98%) or persistence with cell proliferation and evolution to cancer by a small minority (2-5%) (24) . Persistence of nodules could indicate a block in remodeling by differentiation (24) or apoptosis (25) and appears to be linked to enhanced evolution of hepatocellular carcinomas (26) . Table 3 shows the values obtained by morphometric quantification of the number and mean area of total (persistent + remodeling), persistent or remodeling GST-P positive PNL, as well as percentage of the histological section area occupied by these PNL. Compared to CO group, only GGO16 group, but not GGO8, BI8 and BI16 groups, presented lower (P < 0.05) number of total (persistent + remodeling) GST-P positive PNL. Also compared to CO group, GGO8, GGO16, BI8 and BI16 groups presented lower (P < 0.05) number of persistent GST-P positive PNL but not (P > 0.05) of the remodeling ones. All isoprenoid-treated groups presented total (persistent + remodeling) and persistent GST-P positive PNL with smaller (P < 0.05) sizes when compared to CO group. BI16 group, but not all other isoprenoid-treated groups, presented smaller (P < 0.05) remodeling GST-P positive PNL when compared to CO group. Moreover GGO16, BI8 and BI16 groups presented total (persistent + remodeling) and persistent GST-P positive PNL that occupied a smaller (P < 0.05) area of the liver section when compared to CO group. GGO8 group persistent GST-P positive PNL, but not the total (persistent + remodeling) ones, occupied a smaller (P < 0.05) area of the liver section when compared to CO group. There were no differences (P > 0.05) between CO group and all isoprenoid-treated groups regarding the liver section area occupied by remodeling GST-P positive PNL. Altogether, these results regarding GGO and BI inhibitory effects on persistent GST-P positive PNL tended to be more pronounced at the higher dose (16 mg/100 g b.w.) suggesting again a dose-response relationship.
Liver histopathologic examination
Histopathologic examination of H&E stained liver sections revealed the presence of mixed (acidophilic and vacuolated or basophilic and vacuolated) hepatocyte foci and nodules (10) in the CO group. GGO8 and GGO16 groups presented mostly mixed (acidophilic and vacuolated or basophilic and vacuolated) hepatocyte foci (10), whereas BI8 and BI16 groups presented mostly mixed (acidophilic and vacuolated) hepatocyte foci. In addition CO group presented a slight to intense proliferation of oval cells. GGO8, GGO16, BI8 and BI16 groups presented a slight to moderate proliferation of these cells. Figure 4 shows BrdU LI of normal liver tissue and areas surrounding PNL, as well as of the PNL areas themselves at the end of the 7 weeks of experiment. BrdU LI of PNL surrounding normal tissue areas in CO group was higher (P < 0.05) than the BrDU LI of N group. These increase in CO group normal tissue area LI is likely to be related to the fact that these animals were subjected to a 2/3 partial hepatectomy while they were on 2-AAF, a mitoinhibitor. As the mitoinhibitory effects of 2-AAF decrease the LI in the suppressed liver begins to increase. Moreover BrdU LI of PNL areas was higher (P < 0.05) than BrdU LI of the respective surrounding normal tissue areas in CO group. These results agree with the information that during hepatocarcinogenesis cell proliferation increases (27) . Compared to CO group, GGO16 and BI16 groups presented smaller BrdU LI in normal tissue areas surrounding PNL (P < 0.05) and in PNL areas (P < 0.05). There were no differences (P > 0.05) between CO group and GGO8 and BI8 groups regarding BrdU LI in normal tissue areas surrounding PNL and in PNL areas. GGO and BI inhibitory actions on cell proliferation occurred only at the higher dose (16 mg/100 g b.w.) suggesting also a dose-response relationship. Figure 5 shows AI of normal liver tissue and areas surrounding PNL, as well as of the PNL areas themselves at the end of the 7 weeks of experiment. AI of PNL surrounding normal tissue areas in CO group was higher (P < 0.05) than the AI of N group. AI of PNL areas was higher (P < 0.05) than AI of the respective surrounding normal tissue areas in CO, GGO8, GGO16, BI8 and BI16 groups. These results agree with the information that during hepatocarcinogenesis apoptosis also increases (28) . Compared to CO group, BI16 group presented smaller AI both in normal tissue areas surrounding PNL (P < 0.05) and in PNL areas (P < 0.05). There were no differences between CO group and GGO8, GGO16 and BI8 groups regarding AI both in normal tissue areas surrounding PNL (P > 0.05) and in PNL areas (P > 0.05).
Cell proliferation and apoptosis
Total plasma cholesterol Figure 6 shows total plasma cholesterol concentration values of all experimental groups at the end of the 7 weeks of experiment. It can be observed that CO group presented higher (P < 0.05) total plasma cholesterol concentrations compared to the N group. Compared to CO group, GGO16 and BI16 groups presented smaller (P < 0.05) total plasma cholesterol concentrations. There were no differences (P > 0.05) between CO group and GGO8 and BI8 groups regarding total plasma cholesterol concentrations. Inhibitory effects of GGO and BI on total plasma cholesterol concentrations occurred only at the higher dose (16 mg/100 g b.w.) suggesting also a dose-response relationship. Figure 7 shows p65 immunoblot performed with nuclear extracts of normal rat livers and entire livers (nodules + non-nodular surrounding tissues) of animals from CO, GGO8, GGO16, BI8 and BI16 groups. Compared to N group, CO group presented a 50% increase (P < 0.05) of p65 nuclear levels in hepatic cells. On the other hand, GGO16 group presented a 50% reduction (P < 0.05) in the nuclear levels of p65 compared to CO group. No reductions (P > 0.05) in p65 nuclear levels were observed in all other isoprenoid-treated groups also compared to CO group. This inhibitory action of GGO occurred only at the higher dose (16 mg/100 g b.w.) suggesting also a dose-response relationship.
Nuclear p65 Western Blot Analysis
Hepatic DNA Strand Breakage
In this study we opted for staining the formed comets with silver nitrate because of the advantages of the method, for example, to allow the permanent record of the experiment and independent verification of the results, as well as to avoid problems associated with fluorescence such as decay. In addition staining with silver allows the comets to be analyzed using a simple light microscope instead of expensive and complex equipment such as fluorescence microscopes (20, 29) . Table 4 shows comet length values of normal rat livers challenged or not with hydrogen peroxide as well as of entire livers (nodules + non-nodular surrounding tissues) of rats of CO, GGO8, GGO16, BI8 and BI16 groups. Normal rat liver samples challenged with hydrogen peroxide (positive comet assay controls) showed comets with increased lenghts in comparison with those observed in the unchallenged ones (negative comet assay controls; P < 0.05). CO group animals presented comets with increased lenghts compared with those observed in the N group (normal rats; P < 0.05). All isoprenoid-treated groups presented smaller comets (P < 0.05) than those observed in the CO group.
Discussion
In the present study GGO and BI inibited visible hepatocyte nodules and persistent GST-P positive PNL when administered at both doses (8 and 16 mg/100 g b.w.) to Wistar rats submitted to the RH model. To our knowledge these are the first reports on specifically chemopreventive activity of GGO and BI on hepatocarcinogenesis.
Treatment of rats with GGO at doses (0.08 and 0.16% in the diet) (6) similar to those used in our study (8 and 16 mg/100 g b.w.) and prior to the initiation with azoxymethane yielded mixed effects: at the lower dose the isoprenoid inhibited the incidence of aberrant crypt foci whereas at the higher dose it slightly enhanced the incidence of these PNL. On the other hand, our results show inhibitory effects on visible hepatocyte nodules and persistent GST-P PNL when GGO was administered at both doses during the initiation and promotion phases of hepatocarcinogenesis. Moreover, at the higher dose GGO tended to be more effective suggesting a dose-response relationship. In the present study BI presented similar inhibitory effects. Protective BI actions were also reported in a study in female Sprague-Dawley rats where treatment with the isoprenoid for 2 weeks prior to initiation with 7,12-dimethylbenz[a]anthracene and 22 weeks afterwards resulted in inhibition of mammary tumor incidence and multiplicity and in increase of tumor latency (30) .
Besides being well-characterized and particularly adapted to compare effects of compounds potentially able to modulate an ongoing carcinogenic process, one of the most positive features of the RH model is its ability to distinguish the few persistent nodules from the large remodeling ones and thus to allow studies of the nodule to cancer sequence (31) . Interestingly, in our study GGO and BI almost did not present inhibitory actions on remodeling GST-P positive PNL. On the other hand, these isoprenoids markedly inhibited the persistent ones considered to be the precursors of hepatocellular carcinomas (26) . This reinforces protective actions of GGO and BI during hepatocarcinogenesis and indicates that these protective actions by the isoprenoids occur specifically on the relevant PNL regarding chemoprevention.
In the present study GGO and BI were administered continuously for 7 consecutive weeks starting 2 weeks before initiation with DEN and in a period comprising promotion with 2-AAF and partial hepatectomy. BI has been shown to inhibit rat liver microsomal enzymes and it was suggested that it could antagonize the effects of procarcinogens (32) . On the other hand, GGO did not inhibit rabbit liver CYP2E1 (33) . Thus BI but not GGO protective actions in our study could be eventually related to inhibition of DEN and 2-AAF metabolism.
Tumor growth suppression by BI and other isoprenoids is attributed to both the suppression of cell division and the induction of apoptosis (2). BI has been shown to inhibit the proliferation of murine melanoma cells in vitro and in vivo (34) and to induce apoptosis in leukemia, breast and colon adenocarcinoma cells (35) . GGO has been shown to be mainly a potent inducer of apoptosis in leukemia (3), lung cancer (4) and hepatoma (5) cells. It was suggested that apoptosis induction by GGO could be relevant for its chemopreventive activities during hepatocarcinogenesis (5).
Inhibition of cell proliferation was observed in the present study both in PNL and in the surrounding normal tissues after treatment with GGO or BI at the dose of 16 mg/100 g b.w., but not of 8 mg/100 g b.w. Similarly, in a previous study by our group it was observed that geraniol and farnesol, when administered at a dose of 25 mg/100 g b.w. during the initiation and promotion phases of the RH model, also inhibited cell proliferation in hepatic PNL (36) . However, at both doses (8 and 16 mg/100 g b.w.) GGO and BI did not induce apoptosis either in the PNL area or in the normal surrounding area. This suggests that apoptosis induction does not seem to be involved with these isoprenoid chemopreventive activities observed in our study.
It has been described that animals submitted to the RH model present a loss in the hepatic downregulation mechanism of HMG-CoA reductase and of cholesterologenesis (7), as well as increases in hepatic nodule cholesterol (37) . This could explain the higher plasma cholesterol levels observed in CO animals compared to the normal ones.
Treatment of birds, rats or mice with isoprenoids such as BI, limonene or geraniol resulted in HMGCoA reductase inhibition and in total plasma cholesterol concentration decrease (38, 39) . GGO has been shown to markedly inhibit in vitro HMGCoA reductase activity through stimulation of its degradation (40) . In our experiment treatment of rats with 16 mg/100 g b.w. GGO or BI also resulted in significant decrease of total plasma cholesterol concentration. Considering that reduction in total cholesterol concentrations in rats treated with isoprenoids would reflect inhibition of HMGCoA reductase activity (41), we suggest that cell proliferation by GGO and BI in our experiment could be related to inhibition of this enzyme. This would result in reduced synthesis of intermediaries of the mevalonate pathway such as farnesyl and geranylgeranyl pyrophosphates, essential for the prenylation of proteins such as those coded by proto-oncogenes such as ras (2). Interestingly, at the dose of 8 mg/100 g b.w. GGO and BI did not inhibit either total plasma cholesterol concentration or cell proliferation. NF-κB is an important transcription factor that is aberrantly activated in several cancer cells (8) including human hepatocarcinoma cells (42) . Independently of the etiology in human hepatocarcinogenesis, activation of NF-κB is an early event that probably contributes to cell transformation (43) . Recently it has been described that in the initial phases of the RH model NF-κB is highly activated as shown by increased levels of hepatic nuclear p65 levels, through Western blot analysis (44) . Similar results were also observed in our study and this activation of NF-κB seems to be a reflection of the carcinogenic process rather than to be caused by DEN and 2-AAF administered several weeks prior to sacrifice. Since oxidative stress could be responsible for the activation of this transcription factor in the RH model, as previously suggested (44), we decided to use in our experimental conditions the comet assay which enables the evaluation of breaks in the DNA strands and oxidized bases due to ROS action (45) . Interestingly, as previously observed (20) DNA damage was increased in the livers of Wistar rats submitted to the RH model compared to normal rats. This DNA damage seems to be a reflection of the carcinogenic process and not to be caused by DEN or 2-AAF given several weeks prior to sacrifice. Agents with antioxidant activity have been shown to inhibit NF-κB activity, itself considered to be a potential biomarker for oxidative stress (46) . However, although DNA damage was inhibited in our study by treatments at both doses with GGO or BI, isoprenoids with no pronounced antioxidant activity (47, 48) , only treatment with GGO at the higher dose inhibited NF-κB activation. Thus, reduced DNA damage in isoprenoid-treated rats could be due to induction of the repair system as shown for other chemopreventive agents (49) or simply be a reflection of an inhibited carcinogenic process. Probably mechanisms other than inhibition of oxidative stress could account for inhibition of NFκB activation by GGO. A possibility could be interference in the processing of ras, an important activator of this transcription factor (8) or inhibition of IκB phosphorylation and degradation, as well as inhibition of p65 phosporylation, as previously shown for the cyclic isoprenoid ursolic acid (50) . These possibilities remain to be elucidated.
Polyprenoic acid, also known as "acyclic retinoid", has shown efficacy in the prevention of secondary primary hepatocellular carcinomas (51) and has increased de 5-year survival rate of patients with these tumors (52). Polyprenoic acid presents a very similar structure compared to geranylgeranoic acid, also a potential chemopreventive agent and a derivative of GGO (53). Thus, this reinforces the protective actions of GGO observed in our study and suggests that this isoprenoid could be relevant for the chemoprevention of liver cancer in humans.
Altogether, the results of the present study indicate that GGO and BI represent promising chemopreventive agents against hepatocarcinogenesis. Furthermore, inhibition of cell proliferation and DNA damage seems to be important for the isoprenoids' anticarcinogenic actions, while inhibition of NF-κB activation seems to be specifically related to GGO protective actions. 
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